Nvidia invests in Intel foundry to secure artificial intelligence chip supply

Nvidia is finalizing an investment in Intel's foundry business to secure production of advanced artificial intelligence chips and diversify its supply chain. The article does not state the exact investment amount.

Nvidia plans to invest in Intel’s foundry business as a strategic move to secure production capacity for advanced artificial intelligence and data center chips. The article presents the investment as a major endorsement of Intel’s manufacturing comeback, but it does not state the exact investment amount. Nvidia CEO Jensen Huang is quoted saying the collaboration is intended to ensure a resilient, geographically diverse supply base for the artificial intelligence industry’s growth.

The deal is framed as more than a financial commitment. Nvidia would use Intel’s advanced manufacturing processes, including Intel 18A and Intel 20A, which Intel has been working to master. Nvidia’s commitment to source chips from Intel and to co-develop custom chip architectures tied to Intel’s advanced packaging technologies is described as giving Intel Foundry the anchor customer it needs to validate its processes and scale production. For Nvidia, the agreement is described as a risk mitigation step to reduce dependence on a single supplier for its highest-value products.

The article highlights industry implications beyond the two companies. A competitive Intel Foundry is expected to provide alternative capacity outside of Taiwan’s TSMC, potentially easing production bottlenecks and encouraging innovation across the semiconductor ecosystem. Startups and hardware founders are cited as likely to adopt multi-foundry strategies, creating opportunities for firms that build chip design tools for Intel-specific processes, advanced packaging solutions, and supply chain logistics. The piece concludes that the partnership validates the broader semiconductor manufacturing stack as an investible segment tied to the artificial intelligence revolution, promising increased competition and innovation in coming years.

75

Impact Score

CDC vaccine guidance meeting raises alarm

A Senate hearing and a pivotal advisory vote have exposed turmoil at the CDC over vaccine guidance, with former leaders warning that staff are being told to turn their backs on scientific evidence and advisers voting to stop recommending the MMRV vaccine for children under four.

Contact Us

Got questions? Use the form to contact us.

Contact Form

Clicking next sends a verification code to your email. After verifying, you can enter your message.